Clinical trial
Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy
NCT06865430 is registered in ClinicalTrials.gov with Ankara Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy
- Lead sponsor
- Ankara Training and Research Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 4, 2025
- Completion date
- March 4, 2026
- Enrollment
- 82 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate hyperplasia